Micro-CT imaging of multiple K-edge elements using GaAs and CdTe photon counting detectors

Area of Science:

• Medical Imaging
• Materials Science
• Physics

Background:

• Photon-counting micro-CT (PC micro-CT) offers improved spectral information compared to conventional energy-integrating detectors.
• Gallium arsenide (GaAs) and cadmium telluride (CdTe) are promising materials for PC detectors, each with distinct spectral characteristics.
• Optimizing detector materials is crucial for enhancing the capabilities of PC micro-CT, particularly for multi-contrast imaging.

Purpose of the Study:

• To evaluate and compare the performance of GaAs and CdTe photon-counting detectors (PCDs) for PC micro-CT imaging of multiple contrast materials.
• To investigate the benefits of combining GaAs and CdTe PCDs in a single micro-CT system for improved spectral performance and artifact reduction.
• To assess the system's capability in imaging phantoms and biological samples with a wide range of contrast agents.

Main Methods:

• Construction of a dual-detector micro-CT system incorporating both GaAs and CdTe PCDs.
• Imaging of phantoms containing up to five contrast materials with K-edges spanning from 33.2 keV (iodine) to 90.5 keV (bismuth).
• In vivo imaging of a mouse using iodine and bismuth contrast agents to demonstrate dual-targeting capabilities.

Main Results:

• GaAs PCD demonstrated superior low-energy (<50 keV) spectral sensitivity and specificity compared to CdTe.
• GaAs PCD exhibited spectral artifacts and lower photon counts at high energies, indicating inefficient dose utilization.
• The combined GaAs-CdTe dual-detector system achieved higher spectral performance and significant artifact reduction over single-detector configurations.

Conclusions:

• A single GaAs PCD offers advantages at lower energies, but a combined GaAs-CdTe system provides superior overall spectral performance and artifact mitigation in PC micro-CT.
• The developed dual-detector PC micro-CT system shows potential for accurate imaging and the development of novel contrast agents for theranostics.
• This technology advancement could significantly impact the field of targeted diagnostics and therapeutics through enhanced imaging resolution and specificity.